This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
United Kingdom-based GW Pharmaceuticals has produced the world’s first approved cannabis-based medicines for the UK, US, and European markets, Sativex® and Epidiolex®. GW Pharmaceuticals’ research on glioblastoma multiforme (GBM) is important and promising. Note: In May 2021, GW Pharmaceuticals was acquired by Jazz Pharmaceuticals.]
Psychedelics are quickly emerging as alternative methods of treatment for mental illnesses and neurodegenerative conditions — particularly in countries such as Canada. Additionally, the technology backed by the patent will be essential for transforming variable psychedelic raw materials into pharmaceutical-grade standardized extracts.
However, there are indications from studies done with cannabidiol-rich cannabis extracts in Israel that indicate that less side effects (46%) are achieved with a natural cannabis plant extract containing a 20:1 ratio of CBD to THC. Introduction: Recently, a formulation of cannabidiol was approved by the United States FDA.
In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions.
The Dementia Society of America attributes Dementia to rising healthcare costs as billions are spent each year for treatments and research. Pharmaceuticaltreatments for for Dementia often only target symptoms like pain or depression, but those medicines do not cure or prevent the disease. 9-tetrahydrocannabinol (?9-THC)
Most of the conventional methods for treating migraines involve pharmaceutical medication, which has been known to be accompanied by unwanted side effects, especially from opioid based medication. If you have ever suffered through a migraine , you’ll know how much an effective alleviator is necessary. What Does the Study Have to Say?
Valcon Medical A/S Announces Receipt of EU GMP Certification and Start of Commercial Production for Pharmaceutical-Grade Cannabis Concentrates, Intermediary Products, and Medical Formulations (PRNewsfoto/Valcon Medical A/S). and BÜCHI Labortechnik AG, both leaders in cannabis production and processing services. About Valcon Medical.
Marijuana as a treatment for epilepsy. Medical cannabis is showing great potential in the treatment of epilepsy. CONVENTIONAL TREATMENT. One of the goals of treating epilepsy is to allow people to continue to live functional and fulfilling life’s epilepsy treatment. CANNABIS AS A POTENTIAL TREATMENT.
This cannabis-based drug, or rather miraculous medication, is a botanical combination of extracts from the Cyathus striatus fungus and cannabis. This powerful combo was even able to destroy all of the cancer cells without damaging any healthy cells, unlike conventional cancer treatments. What Is Cyathus striatus Fungus?
DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. In both Europe and the United States, the sales of unapproved cannabis products such as smokable flower and full spectrum oils dwarf those of approved pharmaceuticals.
People have been drawn to the extract because of its supposed calming effects. It also said any products that make drug or treatment claims also need to be approved by the FDA. The FDA has approved a pharmaceutical version of CBD to treat rare seizure disorders. NEW YORK — U.S.
For decades, marijuana for cancer treatment seemed out of the question. Even if trials were successful, it is safe to say that using marijuana to treat cancer would meet resistance from the pharmaceutical companies and medical communities alike. The Endocannabinoid System in Cannabis Cancer Treatment.
– August 11, 2022) – MOTAGON, a pharmaceutical company based in Prague and specializing in medical cannabis, has secured a ground-breaking agreement with Europe’s biggest indoor cannabis producer and one of the first cannabis extracts and formulations producers PHCANN INTERNATIONAL.
His team is using novel techniques aimed at untangling the complex interactions between specific plant extracts with cancer cancer cells. 7 The use of cannabis as a cancer treatment was popularized by Rick Simpson, a medical cannabis advocate. GBM is a rare but aggressive brain cancer with very limited treatment options.
More than ever, cannabis can aid in the treatment of chronic disease and as a supplement to other medical interventions and treatments. While traditional pharmaceuticals may alleviate some of the associated symptoms, medical cannabis can aid even further, where pharma leaves off. Antispasmodic. Anticonvulsant/Seizures.
Sometimes traditional veterinary pharmaceuticals may not always be effective for dogs and cats and the side-effects may interfere with a pet’s quality of life. Colorado State University assessed the potency of a Cannabis sativa plant and the cannabidiol (CBD) for the treatment of Arthritic canines and osteoarthritic dogs.
Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. The market for medical cannabis in Germany.
It’s well known that CBD can be very useful in the treatment of mental health disorders, such as anxiety and depression. When you’re buying CBD to treat your seizures, you need to make sure that you buy pure CBD extract. A lot of people are not comfortable with taking pharmaceutical medication. Anti-seizure Properties.
Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. 30 May 2019.
Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) previously approved a prescription medicine derived from cannabis in 2014 to treat muscle spasms and spasticity from multiple sclerosis. Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland.
Some women who chose to use cannabis for postpartum depression say they did so because standard prescription treatments did not help and the side effects from pharmaceuticaltreatments were intolerable. Furthermore, not seeking treatment means not being able to solve the problem, exacerbating the situation all the more.
We are one of the first to successfully complete a commercial shipment of Colombian-manufactured high-CBD pharmaceutical product to Germany available for patients in pharmacies under prescription. In addition, this reflects our increasing know-how to comply with complex and sophisticated regulatory and quality frameworks.
(“Devonian” or the “Corporation”) (TSXv:GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today the signature of a lease Agreement with Hzb Pharma Canada Inc. Tweet this.
and has no accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision.” Pharmaceutical Grade CBD Oil. Epidiolex is a Schedule V controlled substance approved for the treatment of seizures. Idaho Code § 37-2701 et seq. Idaho Code § 37-2704. Conclusion.
The company’s innovative technology enables the provision of an exact amount of active ingredients through oral ingestion, using a high concentration of cannabinoids or medical cannabis extract in a homogeneous, uniform and stable formulation which can be administered in the form of oral capsules, syrups or buccal sprays. Of Cannassure.
This is a strategic opportunity for us to reach the widest audience of customers possible while being the first and, at the moment, the only company with a permit to market cannabis extracts for inhalation in Germany specifically and in Europe in general.
The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. In other cases, CBDA products — or a mixture of CBD and CBDA — may be preferable, if for instance treatments with high doses of CBD have been unsuccessful for you.
Nextleaf Solutions Ltd ( CSE:OILS ) (OTCMKTS:OILFF) has been awarded two patents related to extraction of THC and CBD, bringing its total issued patents to ten. READ: Nextleaf Solutions says its distillation plant on pace to be completed by end of this month. ”
Because they often combine it with other drugs like cocaine or heroin or even legal ‘prescribed’ pharmaceuticals–and those are far more dangerous than cannabis itself! The same cannot be said for alcohol or even caffeine (a more dangerous drug), which can lead to death if consumed excessively enough over time.
(USOTC: PAOG) cited a British Medical Journal case study report published today on the effectiveness of CBD in the treatment of lung cancer and COPD as validation of PAOG’s ongoing research and development of its own respiratory disorder treatment under the name RespRx. 9,199,960). 9,199,960).
Ethypharm has signed an exclusive license agreement with Clever Leaves for the distribution of medical cannabis extracts in Germany, the most important European market for medical cannabis. Clever Leaves will manufacture and supply EU GMP certified medical cannabis extracts sourced from their facilities in Colombia and Portugal.
The FDA’s approval of the drug is just one step toward getting Epidiolex on the market and available to doctors to prescribe as a treatment option. Even though the use of CBD for medicine has the support of the FDA, the methods of extracting CBD and the marketing of CBD products will likely become the subjects of high scrutiny.
The team of researchers’ objective was to assess the effect of medical cannabis on patients with dystonia since it was suggested as a treatment for involuntary contractions of muscles in several case reports and case series. cannabidiol (CBD) , with participants having reported the use of cannabis oil extract, smoking dried cannabis, or both.
Therefore, it makes sense that CBN is most commonly found in aged or improperly stored cannabis, and hardly ever present in fresh flower or low-temp extractions. It is exploring the treatment of pain from osteoarthritis with cannabinoid ratios – specifically, CBD + CBN and CBD + THC versus placebo. Common cannabinoids in cannabis.
Conventional medication methods such as opiates may help terminal patients focus on more palliative treatment options and goals in order to better one’s comfort and overall quality of life during this time. However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill.
This expansive patent would allow Mydecine to scale its coverage in drug development research in lieu of promising discoveries and FDA-approval progress for novel therapeutics, including granting Breakthrough Therapy Designation to MDMA for the treatment of PTSD in recent years. About Mydecine Innovations Group.
Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals. Chronic insomnia often requires a more comprehensive treatment approach. Image by Enecta Cannabis Extracts on Unsplash Medical Marijuana: An Overview What is Medical Marijuana?
He ran clinical trials for big pharma’s GW Pharmaceuticals research division on Epidiolex. Epidiolex is an FDA approved cannabis-based pharmaceutical manufactured drug used in the treatment of seizures. Patel is a member of the Nationwide Children’s Hospital.
NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,
This new research has increased our hopes for an alternate CBD source, which may increase the availability of CBD-based products, reduce purchase costs, and guarantee THC-free extracts. Even more, CBD is the first FDA-approved pharmaceutical drug for two rare forms of epileptic seizures in kids.
An extremely interesting study (Overcoming the Bell-Shaped Dose-Response of Cannabidiol by using Cannabis Extract Enriched in Cannabidiol) was just published out of the Lautenberg Center for General and Tumor Immunology in Jerusalem. Materials Used: Plants, Animals, and Extracts. The purified CBD was acquired from THC Pharm.
Cannabis & Dementia: New Study Explores Pot’s Potential for Treatment. In the decades since the medical marijuana movement began in earnest in the 1970s, cannabis has been anecdotally touted as an effective treatment for a variety of illnesses, including those impacting brain function, such as seizures, anxiety and depression.
Additionally, nausea is a common side effect of cancer treatments, migraines, pregnancy, and more. In a 2020 study on cannabinoids and vomiting, researchers split the group into two: a group that took antiemetic pharmaceuticals and a group that took a CBD/ THC blend. Limonene is the dominant terpene in lemon oil.
The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical trial at the Montefiore Medical Center in New York. Dr. Hollander believes the cannabis extract holds hope for treating autism symptoms in humans based on the success it has had reducing seizure activity in mice.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content